Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis
Epigenetic alterations and microRNA (miRNA) deregulation are common in hepatocellular carcinoma (HCC). The histone H3 lysine 27 (H3K27) tri‐methylating enzyme, enhancer of zeste homolog 2 (EZH2) mediates epigenetic silencing of gene expression and is frequently up‐regulated in human cancers. In this...
Saved in:
Published in | Hepatology (Baltimore, Md.) Vol. 56; no. 2; pp. 622 - 631 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Hoboken
Wiley Subscription Services, Inc., A Wiley Company
01.08.2012
Wiley Wolters Kluwer Health, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!